Nasopharyngeal carcinoma: Significance of changes in epstein‐barr virus‐related antibody patterns following therapy

This publication has 23 references indexed in Scilit:

• Activationin vitro by BUdR of a productive eb virus infection in the epithelial cells of nasopharyngeal carcinoma
  International Journal of Cancer, 1976
• Epstein‐barr virus‐specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma
  International Journal of Cancer, 1976
• Nasopharyngeal carcinoma. IX. Antibodies to EBNA and correlation with response to other EBV antigens in Chinese patients
  International Journal of Cancer, 1975
• Demonstration of epstein‐barr virus‐associated nuclear antigen in nasopharyngeal carcinoma cells from fresh biopsies
  International Journal of Cancer, 1974
• False negative and prozone reactions in tests for antibodies to Epstein-Barr virus-associated nuclear antigen
  International Journal of Cancer, 1974
• Nasopharyngeal carcinoma. IV. Evolution of complement-fixing antibodies during the course of the disease
  International Journal of Cancer, 1973
• Cellular localization of an Epstein‐Barr virus (EBV)‐associated complement‐fixing antigen in producer and non‐producer lymphoblastoid cell lines
  International Journal of Cancer, 1973
• Eb‐virus associated serology in malignant disease: antibody levels to viral capsid antigens (vca), membrane antigens (ma) and early antigens (ea) in patients with various neoplastic conditions
  International Journal of Cancer, 1972
• Demonstration of two distinct components in the early antigen complex of epstein‐barr virus‐infected cells
  International Journal of Cancer, 1971
• Epstein–Barr Virus in Burkitt's Lymphoma and Nasopharyngeal Carcinoma: EBV DNA in Biopsies of Burkitt Tumours and Anaplastic Carcinomas of the Nasopharynx
  Nature, 1970